Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenche Jy

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Seminars in Thrombosis and Hemostasis|November 5, 2010
Microparticle size and its relation to composition, functional activity, and clinical significanceWenche Jy, Lawrence L Horstman, Yeon S Ahn
Neurological Research|May 12, 2006
Multiple sclerosis as a vascular diseaseAlireza Minagar, Wenche Jy, J J Jimenez, et al.
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Endothelial microparticles as markers of endothelial dysfunctionLawrence L Horstman, Wenche Jy, Joaquin J Jimenez, et al.
Seminars in Thrombosis and Hemostasis|June 14, 2019
Tissue Factor-Negative Cell-Derived Microparticles Play a Distinctive Role in Hemostasis: A Viewpoint ReviewLawrence L Horstman, Robert F McCauley, Wenche Jy, et al.
Thrombosis and Haemostasis|April 9, 2008
Cell-derived microparticles: a mediator of inflammation in aortic valve stenosis?Yeon S Ahn, Wenche Jy, Laurence L Horstman, et al.
Acta Haematologica|April 11, 2008
Interleukin-11 for treatment of hepatitis C-associated ITPVincenzo Fontana, Pamela Dudkiewicz, Wenche Jy, et al.
Pharmacological Reports : PR|January 8, 2025
Red cell microparticles produced using high-pressure extrusion enhance both primary and secondary hemostasisSnigdha Sama, Sunjoo Cho, Ashish K Rehni, et al.
American Journal of Hematology|February 1, 2005
Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapyEugene R Ahn, Gabriella Lander, Carlos J Bidot, et al.
Thrombosis and Haemostasis|September 14, 2013
Red cell-derived microparticles (RMP) as haemostatic agentWenche Jy, Max E Johansen, Carlos Bidot, et al.
Journal of Neuroinflammation|September 6, 2006
Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosisWilliam A Sheremata, Wenche Jy, Sylvia Delgado, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Seminars in Thrombosis and Hemostasis|November 5, 2010
Microparticle size and its relation to composition, functional activity, and clinical significanceWenche Jy, Lawrence L Horstman, Yeon S Ahn
Neurological Research|May 12, 2006
Multiple sclerosis as a vascular diseaseAlireza Minagar, Wenche Jy, J J Jimenez, et al.
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Endothelial microparticles as markers of endothelial dysfunctionLawrence L Horstman, Wenche Jy, Joaquin J Jimenez, et al.
Seminars in Thrombosis and Hemostasis|June 14, 2019
Tissue Factor-Negative Cell-Derived Microparticles Play a Distinctive Role in Hemostasis: A Viewpoint ReviewLawrence L Horstman, Robert F McCauley, Wenche Jy, et al.
Thrombosis and Haemostasis|April 9, 2008
Cell-derived microparticles: a mediator of inflammation in aortic valve stenosis?Yeon S Ahn, Wenche Jy, Laurence L Horstman, et al.
Acta Haematologica|April 11, 2008
Interleukin-11 for treatment of hepatitis C-associated ITPVincenzo Fontana, Pamela Dudkiewicz, Wenche Jy, et al.
Pharmacological Reports : PR|January 8, 2025
Red cell microparticles produced using high-pressure extrusion enhance both primary and secondary hemostasisSnigdha Sama, Sunjoo Cho, Ashish K Rehni, et al.
American Journal of Hematology|February 1, 2005
Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapyEugene R Ahn, Gabriella Lander, Carlos J Bidot, et al.
Thrombosis and Haemostasis|September 14, 2013
Red cell-derived microparticles (RMP) as haemostatic agentWenche Jy, Max E Johansen, Carlos Bidot, et al.
Journal of Neuroinflammation|September 6, 2006
Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosisWilliam A Sheremata, Wenche Jy, Sylvia Delgado, et al.
Pageof 6